Xvivo Perfusion AB (publ) (STO:XVIVO)

Market Cap	10.28B
Revenue (ttm)	822.42M
Net Income (ttm)	172.18M
Shares Out	31.50M
EPS (ttm)	5.44
PE Ratio	60.02
Forward PE	66.06
Dividend	n/a
Ex-Dividend Date	n/a

Volume	125,123
Average Volume	116,328
Open	340.00
Previous Close	331.00
Day's Range	324.00 - 344.50
52-Week Range	261.50 - 547.00
Beta	2.10
RSI	22.44
Earnings Date	Apr 24, 2025

About Xvivo Perfusion AB

Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden, the United States, the Netherlands, Italy, North and South America, Europe, the Middle East, Africa, the Asia Pacific, and Oceania. The company offers Kidney Assist Transport, a portable device that allows hypothermic pulsatile perfusion of donor kidneys with oxygenated solution for up to 24 hours; Liver Assist that provides clinicians a c...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 170
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: XVIVO

Financial Performance

In 2024, Xvivo Perfusion AB's revenue was 822.42 million, an increase of 37.63% compared to the previous year's 597.54 million. Earnings were 172.18 million, an increase of 87.52%.